X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (30) 30
index medicus (27) 27
humans (24) 24
aged (15) 15
female (15) 15
male (13) 13
middle aged (13) 13
adult (12) 12
chemotherapy (12) 12
colorectal cancer (12) 12
colorectal neoplasms - drug therapy (11) 11
colorectal neoplasms - genetics (9) 9
metastasis (9) 9
cancer (8) 8
colorectal neoplasms - pathology (8) 8
medicine & public health (7) 7
mutation (7) 7
cetuximab (6) 6
neoplasm metastasis (6) 6
prognosis (6) 6
research (6) 6
therapy (6) 6
aged, 80 and over (5) 5
analysis (5) 5
drug resistance, neoplasm (5) 5
health aspects (5) 5
panitumumab (5) 5
tumors (5) 5
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
bevacizumab (4) 4
biomarkers (4) 4
breast cancer (4) 4
care and treatment (4) 4
disease-free survival (4) 4
egfr (4) 4
kras (4) 4
treatment outcome (4) 4
trial (4) 4
antibodies, monoclonal - therapeutic use (3) 3
cancer patients (3) 3
cancer therapies (3) 3
colony-stimulating factor (3) 3
colorectal carcinoma (3) 3
dna methylation (3) 3
dose-dense chemotherapy (3) 3
gene copy number (3) 3
genetic aspects (3) 3
hematology, oncology and palliative medicine (3) 3
irinotecan (3) 3
liquid biopsy (3) 3
metastatic colorectal cancer (3) 3
methylation (3) 3
monoclonal antibodies (3) 3
mutations (3) 3
oncology, experimental (3) 3
plus (3) 3
proto-oncogene proteins - genetics (3) 3
proto-oncogene proteins p21 (3) 3
ras proteins - genetics (3) 3
regorafenib (3) 3
resistance (3) 3
retrospective studies (3) 3
settore med/06 - oncologia medica (3) 3
signal transduction (3) 3
1st-line treatment (2) 2
adenocarcinoma - genetics (2) 2
alleles (2) 2
american-society (2) 2
anemia - chemically induced (2) 2
animals (2) 2
antibodies, monoclonal, humanized (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
article (2) 2
biological markers (2) 2
biomarkers, tumor - metabolism (2) 2
biomedicine general (2) 2
biomedicine, general (2) 2
breast neoplasms - drug therapy (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
cells (2) 2
clinical trials (2) 2
colorectal neoplasms - diagnosis (2) 2
colorectal neoplasms - metabolism (2) 2
colorectal-cancer (2) 2
combination (2) 2
combined modality therapy (2) 2
digital pcr (2) 2
disease progression (2) 2
docetaxel (2) 2
drug administration schedule (2) 2
drug resistance, neoplasm - drug effects (2) 2
drug therapy (2) 2
epidermal growth factor (2) 2
epirubicin (2) 2
expression (2) 2
filgrastim (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 738 - 746
Journal Article
Nature, ISSN 0028-0836, 06/2012, Volume 486, Issue 7404, pp. 532 - 536
Journal Article
Journal Article
Modern Pathology, ISSN 0893-3952, 11/2015, Volume 28, Issue 11, pp. 1481 - 1491
Journal Article
Cancer Discovery, ISSN 2159-8274, 04/2017, Volume 7, Issue 4, pp. 400 - 409
Entrectinib, a potent oral inhibitor of the tyrosine kinases TRKA/B/C, ROS1, and ALK, was evaluated in two phase I studies in patients with advanced or... 
REARRANGEMENT | ONCOGENE | ONCOLOGY | ANALOG SECRETORY CARCINOMA | LANDSCAPE | KINASE FUSIONS | SARCOMAS | ETV6-NTRK3 GENE FUSION | CRIZOTINIB | GENOMIC ALTERATIONS | CLINICAL-RESPONSE | Benzamides - pharmacokinetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Receptor, trkA - antagonists & inhibitors | Male | Receptor, trkB - genetics | Indazoles - administration & dosage | Protein Kinase Inhibitors - adverse effects | Mammary Analogue Secretory Carcinoma - genetics | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Membrane Glycoproteins - antagonists & inhibitors | Receptor, trkC - genetics | Anaplastic Lymphoma Kinase | Melanoma - genetics | Colorectal Neoplasms - drug therapy | Receptor, trkB - antagonists & inhibitors | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Benzamides - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Crizotinib | Protein Kinase Inhibitors - pharmacokinetics | Proto-Oncogene Proteins - antagonists & inhibitors | Pyridines - administration & dosage | Carcinoma, Non-Small-Cell Lung - genetics | Receptor, trkC - antagonists & inhibitors | Melanoma - pathology | Mammary Analogue Secretory Carcinoma - drug therapy | Membrane Glycoproteins - genetics | Protein Kinase Inhibitors - administration & dosage | Sequestosome-1 Protein - genetics | Pyrazoles - administration & dosage | Indazoles - pharmacokinetics | Receptor Protein-Tyrosine Kinases - genetics | Oncogene Proteins, Fusion - genetics | Melanoma - drug therapy | Adolescent | Receptor, trkA - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Indazoles - adverse effects | Colorectal Neoplasms - pathology | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, pp. e62264 - e62264
Journal Article
BMC Cancer, ISSN 1471-2407, 06/2011, Volume 11, Issue 1, pp. 247 - 247
Journal Article
by Bellelli, Giuseppe and Morandi, Alessandro and Di Santo, Simona G and Mazzone, Andrea and Cherubini, Antonio and Mossello, Enrico and Bo, Mario and Bianchetti, Angelo and Rozzini, Renzo and Zanetti, Ermellina and Musicco, Massimo and Ferrari, Alberto and Ferrara, Nicola and Trabucchi, Marco and Boffelli, Stefano and Stefano, Fabio Di and Filippi, Francesco De and Guerini, Fabio and Bertoletti, Erik and March, Albert and Margiotta, Alessandro and Mecocci, Patrizia and Addesi, Desireè and Fantò, Fausto and Dijik, Babette and Porrino, Paola and Cotroneo, Antonino Maria and Galli, Giovanni and Bruni, Amalia Cecilia and Bernardini, Bruno and Corsini, Carla and Cagnin, Annachiara and Zurlo, Amedeo and Barbagallo, Giuseppe and Lunardelli, Maria Lia and Martini, Emilio and Battaglia, Giuseppe and Latella, Raffaele and Petritola, Donatella and Sinforiani, Elena and Cester, Alberto and Formilan, Marino and Carbone, Pasqualina and Appollonio, Ildebrando and Cereda, Diletta and Tremolizzo, Lucio and Bottacchi, Edo and Lucchetti, Lucio and Mariani, Claudio and Rapazzini, Piero and Romanelli, Giuseppe and Marengoni, Alessandra and Zuliani, Giovanni and Bianchi, Lara and Suardi, Teresa and Muti, Ettore and Bottura, Renato and Sgrò, Giovanni and Mandas, Antonella and Serchisu, Luca and Crippa, Patrizia and Ivaldi, Claudio and Ungar, Andrea and Villani, Daniele and Raimondi, Clara and Mussi, Chiara and Isaia, Giancarlo and Provenzano, Giuseppe and Mari, Daniela and Odetti, Patrizio and Monacelli, Fiammetta and Incalzi, Raffaele Antonelli and Pluderi, Alice and Bellamoli, Claudio and Terranova, Luciano and Scarpini, Elio and D'Amico, Ferdinando and Cavallini, Maria Chiara and Guerrini, Gianbattista and Scotuzzi, Anna Maria and Chiarello, Antonino and Pilotto, Alberto and Tognini, Sara and Dell'Aquila, Giuseppina and Toigo, Gabriele and Ceschia, Giuliano and Piccinini, Maristella and Fabbo, Andrea and Zoli, Marco and Forti, Paola and Wenter, Christian and Basile, Giorgio and Lasagni, Anna and Padovani, Alessandro and Rozzini, Luca and Cottino, Maria and Vitali, Silvia and Tripi, Gabriele and Avanzi, Stefano and Annoni, Giorgio and ... and Italian Study Grp Delirium ISGoD and Italian Study Group on Delirium (ISGoD)
BMC Medicine, ISSN 1741-7015, 07/2016, Volume 14, Issue 1, pp. 106 - 106
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2013, Volume 19, Issue 8, pp. 2265 - 2272
Journal Article